Glycopyrronium bromide/Neostigmine metilsulfate | Interleukin Related interleukin-related.com

Product Name :
Glycopyrronium bromide/Neostigmine metilsulfate

Search keywords :
Cholinesterase

drugId :
null

Target Vo:
Muscarinic acetylcholine receptor

Target Vo Short Name :
mAChRs

Moa_Name:
Muscarinic acetylcholine receptor antagonists

First Approval Country :

First Approval Date Filter:
2020

Origin Company_Name :
Sintetica Gmbh

Active Company_Name :
Azurity Pharmaceuticals Inc

Active Indication_Name:
Drug Overdose

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Insulin Mouse mAb custom synthesis
Rituximab Description
eIF4A1 Antibody (YA774): eIF4A1 Antibody (YA774) is a non-conjugated and Mouse origined monoclonal antibody about 46 kDa, targeting to eIF4A1 (6D7). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts